AwardedPOLGoods
Dostawa leków i wyrobów medycznych
- Published
- Published 28 May 2026
- Deadline
- Closed 29 June 2026
Overview
Górnośląskie Centrum Medyczne procured the supply of pharmaceutical medicines and medical devices under an NFZ (National Health Fund) program, comprising three tasks: immunoglobulin human normal, sotatercept powder and solvent for injection, and ravulizumab concentrate for infusion. The contract was awarded on 8 July 2026 for 5,864,634 PLN to three suppliers: AstraZeneca Kereskedelmi és Szolgáltató Korlátolt Felelősségű Társaság, Takeda Pharma Sp. z o.o., and Urtica Sp. z o.o.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 28 May 2026
- Deadline
- Closed
Pharmaceutical productsPharmaceutical articles
Award outcome
- Awarded value
- PLN 5,864,634
- Award date
- 8 July 2026
- Contract period
- — → 26 June 2027
- AstraZeneca Kereskedelmi és Szolgáltató Korlátolt Felelősségű Társaság
- Takeda Pharma Sp. z o.o.
- Urtica Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
21 July 2026
Contract Notice
28 May 2026
Contracting authority
Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach
Procuring entityKatowice, POL
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.